¼±Åà - È»ìǥŰ/¿£ÅÍŰ
´Ý±â - ESC
KMLE °Ë»ö
°Ë»ö ¼³Á¤
¿Â¶óÀÎ ÀÇÇмÀû
ÀÇÇпë¾î »çÀü
ÀÇÇоà¾î
ÀÇÇлçÀü
ÇÑ¿µ/¿µÇÑ»çÀü
¿µ¿µ»çÀü
»çÀÌÆ® ¼Ò°³
Àç°Ë»ö
"MYO"¿¡ ´ëÇÑ Çѱ¹Ç¥ÁØÁúº´»çÀκзù ¼¼ºÎ °Ë»ö °á°úÀÔ´Ï´Ù
Çѱ¹Ç¥ÁØÁúº´»çÀκзù ¾àÀÚ ¸ÂÃã °Ë»ö °á°ú :
5
ÆäÀÌÁö:
3
ÄÚµå
¿µ¹®
ÇѱÛ
G70.9
Myoneural disorder, unspecified
»ó¼¼ºÒ¸íÀÇ ±Ù½Å°æ¼º Àå¾Ö
G72.2
Myopathy due to other toxic agents
±âŸ µ¶¼º¹°Áú¿¡ ÀÇÇÑ ±ÙÀ°º´Áõ
G73.5*
Myopathy in endocrine diseases
³»ºÐºñ¼º Áúȯ¿¡¼ÀÇ ±ÙÀ°º´Áõ
G73.4*
Myopathy in infectious and parasitic diseases classified elsewhere
´Þ¸® ºÐ·ùµÈ °¨¿°¼º ¹× ±â»ýÃæ¼º Áúȯ¿¡¼ÀÇ ±ÙÀ°º´Áõ
G73.6*
Myopathy in metabolic diseases
´ë»ç¼º Áúȯ¿¡¼ÀÇ ±ÙÀ°º´Áõ
ÀÌÀü
´ÙÀ½
ÀÌ ¾Æ·¡ ºÎÅÍ´Â °á°ú°¡ ¾ø½À´Ï´Ù.
Çѱ¹Ç¥ÁØÁúº´»çÀκзù ¾àÀÚ À¯»ç °Ë»ö °á°ú :
0
ÆäÀÌÁö:
3
ÄÚµå
¿µ¹®
ÇѱÛ
ÀÌÀü
ÅëÇÕ°Ë»ö ¿Ï·á
ÀÌÀü
´ÙÀ½